New PI warning incoming

Pfizer to add warning to vaccine PI on heart-related adverse events The TGA is currently working with Pfizer to add a warning statement to the Product Information (PI) of its Comirnaty vaccine to include myocarditis and pericarditis as adverse events identified through post-marketing experience. It noted that the European Medicines Agency’s committee on pharmacovigilance risk

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘It's a win for the team.’
Next Keeping up with biosimilars